Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 31834391.
- Also identified by DOI 10.1001/jamanetworkopen.2019.17379 and PMC identifier 6938676.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this cohort study, pricing data from January 2007 to June 2018 from SSR Health were used to determine how list prices, net prices, and discounts for the originator biologics changed with biosimilar competition.
Medical subject headings
- Biological Factors
- Biosimilar Pharmaceuticals
- Commerce
- Drug Costs
- Economic Competition